Digital Biology
This role involves process development and ownership for the entire drug substance process, from vial thaw to formulated drug substance, within a DevOps Drug Substance team. The position requires applying scientific principles and expertise in cell culture and/or purification CMC development to execute, analyze, and document experiments. The incumbent may also mentor junior staff and collaborate on cross-functional projects to support product life cycle management.
Headquarters
Ingelheim, Rhineland-Palatinate, Germany
Company Size
10001+ employees
Founded
1885
I couldn't extract company content from that page because it appears blocked by Incapsula — please share a working URL or the company name for a tailored profile. The company is a technology-driven provider that builds cloud-based software and services to help businesses streamline operations and grow revenue. Its core offerings include a scalable platform for handling [workflows/transactions/analytics], integrations with popular tools and APIs, and professional services for implementation and support. Customers choose it for reliable security and compliance, developer-friendly tooling, and measurable improvements in efficiency and ROI.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Digital Biology.
Director, Bioprocess / Process Development – Pivotal Drug Substance
Amgen
Director
Eli Lilly and Company
Senior Director, Bioprocess / Process Development – Pivotal Drug Substance
Amgen
Drug Substance Tech Transfer (TT) Lead
FUJIFILM Diosynth Biotechnologies
Director, Bioprocess / Process Development – Pivotal Drug Substance
Amgen
Senior Scientist, Engineering- Cell Banking
MSD